Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology
毛细血管畸形:从体细胞 GNAQ 突变到内皮生物学破坏
基本信息
- 批准号:10630310
- 负责人:
- 金额:$ 84.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAllelesAngiopoietin-2Animal ModelAutomobile DrivingBar CodesBiologyBlood VesselsBlood capillariesBrainCell SeparationCell modelCell physiologyCellsChoroidCognitiveCollaborationsCoupledCutaneousDataDefectDermisDevelopmentEndothelial CellsEndotheliumEventExperimental ModelsEyeFaceFunctional disorderG alpha q ProteinG-substrateGNAQ geneGene Expression ProfileGenesGenomicsGenotypeGlaucomaGoalsGrowthHematopoieticHemorrhageHeterogeneityHeterotrimeric G Protein SubunitHistologicHumanImageImpairmentImplantIn Situ HybridizationIn VitroInfantInflammatoryKnock-inLeadLeptomeningesLesionMalignant NeoplasmsMassachusettsMediatorMedicalMedical centerModelingMolecularMorphogenesisMusMutationNF-kappa BNeurocutaneous SyndromesNeurologicNoduleNude MicePathogenesisPathologyPathway interactionsPatientsPharmaceutical PreparationsPharmacotherapyPhenotypePhospholipasePlayPort-Wine StainProtein Kinase CReportingResistanceRetinal DetachmentRoleSeizuresSignal TransductionSkinSmall Interfering RNASomatic MutationSortingSpecimenStainsSturge-Weber SyndromeSurfaceTNFSF5 geneTamoxifenTechnologyTestingTimeTissue EngineeringTranscriptUniversitiesWorkZebrafishcausal variantcell typecerebral capillarydrug candidatedrug testinghigh riskimprovedin vivoinsightknock-downmalformationmouse modelmutantnervous system disordernovelpreventresponseshear stresssingle-cell RNA sequencingskeletalsmall hairpin RNAsmall molecule inhibitorsoft tissuestroke-like episodesubcutaneoustissue repairtranscriptome sequencingvenule
项目摘要
Project Abstract
Our studies are focused on capillary malformation (CM) (previously referred to as “port-wine stain”), the most
common type of vascular malformation. CM, excessive, enlarged capillary-like vessels just below the surface
of the skin, are sporadic congenital lesions that darken, form nodules, and cause soft-tissue and skeletal
overgrowth beneath the stain. Sturge-Weber syndrome (SWS) is a neurocutaneous disorder associated with
CMs of the face, leptomeninges, and the choroid of the eye; patients suffer from neurological defects and
glaucoma. Importantly, drug treatment for CMs does not exist and there is no cure.
The 2013 discovery of a somatic activating mutation in GNAQ (p.R183Q) in non-syndromic cutaneous CMs
and SWS CMs set the stage for molecular studies of this understudied vascular malformation. GNAQ encodes
Gαq, the α-subunit of the heterotrimeric Gq protein that activates phospholipase Cβ. We showed that the
GNAQ R183Q allele is enriched in the endothelial cell (EC) sorted from cutaneous CM and SWS brain
specimens. We have worked on creating cellular and mouse models to elucidate how the GNAQ mutation
affects EC function, how these alterations lead to CM, and how we can prevent the formation or growth of CM.
We show that human ECs with the R183Q mutation do not respond properly to laminar shear stress, fail to
form an endothelial barrier, and form enlarged CM-like vessels when implanted into mice. We implicate protein
kinase C (PKC) and angiopoietin-2 (ANGPT2) as potential targets to reverse the GNAQ R183Q-driven CM.
We are making strong progress towards an inducible, endothelial-specific knock-in of Gnaq R183Q in mice in
which we have found CM-like lesions upon tamoxifen-induced expression of the knocked-in mutant allele.
In this proposal we will identify the breadth of cell types that carry the somatic GNAQ R183Q allele and how
the mutation alters the transcriptional profile versus non-mutant cells of the same phenotype (Aim 1). We will
develop novel animal models in mice and zebrafish to elucidate the cellular steps leading to CM and will use
them as platforms for testing candidate drugs (Aim 2). We will deeply interrogate the role of (ANGPT2) as a
downstream functional mediator of constitutively active, mutant Gαq (Aim 3). These studies will deepen our
understanding of how Gαq activity participates in capillary morphogenesis, result in the first animal models for
CM/SWS, and provide a platform to test drugs that can prevent or regress CM. Discoveries about the
pathophysiology of CM will also help us understand the mechanisms that underlie additional vascular lesions
and improve our ability to identify new pathways for preventing vascular overgrowth (e.g., cancer) and
promoting vascular growth during tissue repair or engineering.
项目摘要
我们的研究集中于毛细血管畸形(CM)(以前称为“港口染色”),是最多的
常见的血管畸形类型。 CM,超出表面下方的超级毛细管样血管
皮肤的是零星的先天性病变,形成结节并引起软组织和骨骼
在污渍下过度生长。 Sturge-Weber综合征(SWS)是一种与
脸部的CM,瘦素和眼睛的脉络膜;患者患有神经系统缺陷,
青光眼。重要的是,CMS的药物治疗不存在,也无法治愈。
2013年在非综合皮肤CMS中发现了GNAQ(P.R183Q)中的体细胞激活突变
SWS CM为这项理解的血管畸形的分子研究奠定了基础。 GNAQ编码
GαQ,激活磷脂酶Cβ的异三聚体GQ蛋白的α-亚基。我们证明了
GNAQ R183Q等位基因富集在皮肤CM和SWS脑的内皮细胞(EC)中
标本。我们一直在创建细胞和小鼠模型,以阐明GNAQ突变如何
影响EC功能,这些变化如何导致广告以及我们如何防止广告的形成或增长。
我们表明,具有R183Q突变的人类EC对层状剪切应力没有正确的反应,无法
形成一个内皮屏障,并植入小鼠时形成增强的CM样血管。我们暗示蛋白质
激酶C(PKC)和Angiopoietin-2(Angpt2)作为逆转GNAQ R183Q驱动的商业的潜在目标。
我们正在朝着小鼠的GNAQ R183Q进行诱导,内皮特异性敲击方面的进步
我们发现了在他莫昔芬诱导的敲入突变等位基因表达上的CM样病变。
在此提案中,我们将确定带有体细胞GNAQ R183Q等位基因的细胞类型的广度以及如何
突变改变了相同表型的转录谱与非突变细胞(AIM 1)。我们将
在小鼠和斑马鱼中开发新型动物模型,以阐明导致CM的细胞步骤,并将使用
它们是测试候选药物的平台(AIM 2)。我们将深入询问(Angpt2)作为一个
组成性活性,突变GαQ的下游功能介质(AIM 3)。这些研究将加深我们
了解GαQ活性参与者如何参与毛细血管形态发生,从而导致了第一个动物模型
CM/SWS,并提供一个可以预防或回归CM的药物的平台。关于
CM的病理生理学还将帮助我们了解其他血管病变的机制
并提高我们确定防止血管过度生长(例如癌症)和
在组织修复或工程期间促进血管生长。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A somatic missense mutation in GNAQ causes capillary malformation.
- DOI:10.1097/moh.0000000000000500
- 发表时间:2019-05
- 期刊:
- 影响因子:3.2
- 作者:Bichsel C;Bischoff J
- 通讯作者:Bischoff J
MRC1 and LYVE1 expressing macrophages in vascular beds of GNAQ p.R183Q driven capillary malformations in Sturge Weber syndrome.
Sturge Weber 综合征中 GNAQ p.R183Q 血管床中表达 MRC1 和 LYVE1 的巨噬细胞导致毛细血管畸形。
- DOI:10.1186/s40478-024-01757-4
- 发表时间:2024
- 期刊:
- 影响因子:7.1
- 作者:Nasim,Sana;Bichsel,Colette;Dayneka,Stephen;Mannix,Robert;Holm,Annegret;Vivero,Mathew;Alexandrescu,Sanda;Pinto,Anna;Greene,ArinK;Ingber,DonaldE;Bischoff,Joyce
- 通讯作者:Bischoff,Joyce
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joyce E. Bischoff其他文献
Joyce E. Bischoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joyce E. Bischoff', 18)}}的其他基金
Pediatric Surgeon-Scientist Training Program in Vascular Diseases
小儿外科医生-科学家血管疾病培训计划
- 批准号:
10331916 - 财政年份:2022
- 资助金额:
$ 84.07万 - 项目类别:
Pediatric Surgeon-Scientist Training Program in Vascular Diseases
小儿外科医生-科学家血管疾病培训计划
- 批准号:
10619547 - 财政年份:2022
- 资助金额:
$ 84.07万 - 项目类别:
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology
毛细血管畸形:从体细胞 GNAQ 突变到内皮生物学破坏
- 批准号:
10206231 - 财政年份:2016
- 资助金额:
$ 84.07万 - 项目类别:
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology
毛细血管畸形:从体细胞 GNAQ 突变到内皮生物学破坏
- 批准号:
10058384 - 财政年份:2016
- 资助金额:
$ 84.07万 - 项目类别:
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology
毛细血管畸形:从体细胞 GNAQ 突变到内皮生物学破坏
- 批准号:
10414083 - 财政年份:2016
- 资助金额:
$ 84.07万 - 项目类别:
Capillary malformation: From somatic GNAQ mutations and disrupted endothelial biology
毛细血管畸形:来自体细胞 GNAQ 突变和内皮生物学破坏
- 批准号:
9244833 - 财政年份:2016
- 资助金额:
$ 84.07万 - 项目类别:
Blood vessel assembly from multipotent hemangioma-derived stem cells
来自多能血管瘤干细胞的血管组装
- 批准号:
8248244 - 财政年份:2009
- 资助金额:
$ 84.07万 - 项目类别:
Blood vessel assembly from multipotent hemangioma-derived stem cells
来自多能血管瘤干细胞的血管组装
- 批准号:
10609870 - 财政年份:2009
- 资助金额:
$ 84.07万 - 项目类别:
Blood vessel assembly from multipotent hemangioma-derived stem cells
来自多能血管瘤干细胞的血管组装
- 批准号:
9973341 - 财政年份:2009
- 资助金额:
$ 84.07万 - 项目类别:
Blood vessel assembly from multipotent hemangioma-derived stem cells
来自多能血管瘤干细胞的血管组装
- 批准号:
7789467 - 财政年份:2009
- 资助金额:
$ 84.07万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于等位基因非平衡表达的鹅掌楸属生长量杂种优势机理研究
- 批准号:32371910
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Drug Development for Pediatric Capillary Malformation
治疗小儿毛细血管畸形的药物开发
- 批准号:
10675489 - 财政年份:2022
- 资助金额:
$ 84.07万 - 项目类别:
Drug Development for Pediatric Capillary Malformation
治疗小儿毛细血管畸形的药物开发
- 批准号:
10536819 - 财政年份:2022
- 资助金额:
$ 84.07万 - 项目类别:
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology
毛细血管畸形:从体细胞 GNAQ 突变到内皮生物学破坏
- 批准号:
10206231 - 财政年份:2016
- 资助金额:
$ 84.07万 - 项目类别:
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology
毛细血管畸形:从体细胞 GNAQ 突变到内皮生物学破坏
- 批准号:
10058384 - 财政年份:2016
- 资助金额:
$ 84.07万 - 项目类别:
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology
毛细血管畸形:从体细胞 GNAQ 突变到内皮生物学破坏
- 批准号:
10414083 - 财政年份:2016
- 资助金额:
$ 84.07万 - 项目类别: